PALISADE BIO, INC. Public Float
PALISADE BIO, INC. (PALI) had Public Float of $11.20 million as of 2025-06-30, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-20
- 2025-06-30: Entity Public Float $11.20M.
- 2024-06-30: Entity Public Float $4.30M.
- 2023-06-30: Entity Public Float $11.60M.
- 2022-06-30: Entity Public Float $8.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $11.20M 10-K · filed 2026-03-20 |
| 2024-06-30 | $4.30M 10-K · filed 2025-03-24 |
| 2023-06-30 | $11.60M 10-K · filed 2024-03-26 |
| 2022-06-30 | $8.10M 10-K · filed 2023-03-22 |
| 2021-06-30 | $39.20M 10-K · filed 2022-03-17 |
| 2020-06-30 | $12.44M 10-K · filed 2021-03-22 |
| 2019-06-30 | $4.58M 10-K · filed 2020-03-27 |
| 2018-06-30 | $14.06M 10-K · filed 2019-03-22 |
| 2017-06-30 | $55.42M 10-K · filed 2018-04-02 |
| 2016-06-30 | $30.67M 10-K · filed 2017-03-23 |
| 2015-06-30 | $168.90M 10-K · filed 2016-03-14 |
| 2014-06-30 | $352.40M 10-K · filed 2015-03-16 |
| 2013-06-30 | $99.51M 10-K · filed 2014-03-10 |
| 2012-06-30 | $45.89M 10-K · filed 2013-03-15 |
| 2011-06-30 | $64.96M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |